Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Codexis (CDXS) EBT (2016 - 2025)

Codexis has reported EBT over the past 16 years, most recently at $9.6 million for Q4 2025.

  • Quarterly results put EBT at $9.6 million for Q4 2025, up 192.73% from a year ago — trailing twelve months through Dec 2025 was -$43.9 million (up 32.67% YoY), and the annual figure for FY2025 was -$43.9 million, up 32.67%.
  • EBT for Q4 2025 was $9.6 million at Codexis, up from -$19.6 million in the prior quarter.
  • Over the last five years, EBT for CDXS hit a ceiling of $9.6 million in Q4 2025 and a floor of -$34.9 million in Q3 2023.
  • Median EBT over the past 5 years was -$10.9 million (2024), compared with a mean of -$12.0 million.
  • Biggest five-year swings in EBT: crashed 524.13% in 2022 and later skyrocketed 192.73% in 2025.
  • Codexis' EBT stood at -$10.1 million in 2021, then decreased by 23.03% to -$12.5 million in 2022, then surged by 42.53% to -$7.2 million in 2023, then plummeted by 44.94% to -$10.4 million in 2024, then skyrocketed by 192.73% to $9.6 million in 2025.
  • The last three reported values for EBT were $9.6 million (Q4 2025), -$19.6 million (Q3 2025), and -$13.3 million (Q2 2025) per Business Quant data.